在刚刚结束不久的北京国际风能大会上，南京高速齿轮制造有限公司参展的新一代10MW（兆瓦）级主 齿轮箱、偏航变桨齿轮箱等系列产品一经亮相，便吸引了众多主机厂商的关注。 "新一代10MW级主齿轮箱，集成了齿轮参数优化、第二代滑动轴承和可靠性结构设计提升等多项先进 技术，在扭矩密度、传动效率、可靠性及经济性上表现优异，可以显著提升产品全生命周期运行可靠 性。"南高齿董事长胡吉春介绍，目前，该系列滑动轴承齿轮箱累计交付超8000台，其中逾5000台已在 风电场稳定运行。 南高齿从1969年成立之初便锚定齿轮传动赛道，历经50余载，见证了中国装备制造业从依赖进口到自主 可控的转变。如今，企业已从"求生存"迈向"谋发展"，成长为全球布局的高新技术企业。 "在企业发展过程中，我们构建了'技术创新+管理提升'双轮驱动体系，搭建起以客户为中心的NGCQS （体系建设）大质量管理运营平台，形成覆盖产品全生命周期的闭环质量管控体系。"胡吉春说，企业 从研发端、组织端、服务端、制造端、供应链端等维度协同强化、精准管控，同时配套"流程符合性、 绩效完成度、可持续发展性"3个维度评估体系，推动质量管理不断升级完善。目前，企业已构建起"全 ...

Core Points - Panlong Pharmaceutical (002864) has successfully passed the rigorous evaluation by the China National Accreditation Service for Conformity Assessment (CNAS) and obtained the laboratory accreditation certificate, effective from June 9, 2025, to June 8, 2031, marking a new benchmark for high-quality development in the traditional Chinese medicine industry [2][3] - The CNAS accreditation signifies that the company's quality control system meets the highest international standards, allowing for mutual recognition of testing data across over 100 economies globally, enhancing the legal authority and international credibility of its testing results [2][3] Company Upgrades - The accreditation will drive upgrades in three key areas: - Research and Development: Accelerating the validation of the effectiveness of new traditional Chinese medicines through a high-standard testing platform [3] - Production: Ensuring a lean production process that guarantees a comprehensive traceability system from raw materials to finished products [3] - Market: Strengthening customer trust and providing international recognition to the "Panlong" brand [3] Strategic Validation - The CNAS recognition is seen as validation of the company's strategy to build its brand on quality, with plans to integrate modern testing technologies with traditional Chinese medicine wisdom, ensuring that every medicinal material and product meets global standards [3]